Coronavirus COVID-19 Information
- Information for patients who have a scheduled test, appointment or telehealth visit
- Information for hospital visitors
- Donations: How you can help
Dana-Farber Cancer Institute and the Lifespan Cancer Institute have created a strategic alliance to advance cancer treatment and research.
Dana-Farber and Lifespan Cancer Institute support the expansion of clinical trials, access for Lifespan physicians to cancer-specific disease expertise for complex cases, and the launch of a new program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber/Brigham and Women's Cancer Center, and care surrounding the transplant provided at Lifespan Cancer Institute in Providence.
The two organizations share patient information through their respective cancer-specific electronic health record systems and will use the same clinical trials management platform, resulting in better care coordination.
A top priority of Dana-Farber and Lifespan Cancer Institute’s work together is the ability to offer the latest and most advanced clinical trials to patients in Rhode Island. While many of these trials are developed at and provided by Dana-Farber, there are also opportunities for clinical trials developed at the Lifespan Cancer Institute to be offered to Dana-Farber patients. Increasing access to diverse patient populations is a common goal to help accelerate the development of new therapies.
Other areas we are exploring include genomics and precision medicine, cancer disparities, innovation in the delivery of cancer care, and potential synergies in basic research. The two organizations have collaborated on a multi-site grant application for genomics with a health disparities component.